Success Stories: EB-1B Petition Approved for Research Associate in Kansas in the Field of Molecular Biology

Client’s Testimonial:

 

Thanks very much for your help on my I-140 approval. Definitely I will refer you to my friends for their green card applications, actually I already referred your firm to some of my friends  [...] I truly appreciate your expertise, your team members' effort, and cooperation from them. It is a very helpful, friendly and expertised service I got from you. I am very happy working with you and I will be very happy to recommend your name on LinkedIn too.

 


We Received EB-1B Approval for a Research Associate in the Field of Molecular Biology on November 20th, 2014 (Approval Notice)


General Field: Molecular Biology

Position at the Time of Case Filing: Research Associate

Petitioner: A University

Country of Origin:  India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Kansas

Approval Notice Date: November 20th, 2014

Processing Time:3 Months, 22 Days

 


Case Summary:

At North America Immigration Law GroupWeGreened.com, we recently received an EB-1B approval for a Research Associate in the field of Molecular Biology. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for her EB-1B petition. Her specialized research has focused on identifying the cellular targets involved in cancer pathogenesis. Her research work had resulted in 10 peer-reviewed scientific articles, 4 peer-reviewed conference abstracts, and 12 presentations at national and international conferences. She had also reviewed 4 manuscripts for journals at the time we filed the case. Furthermore, the beneficiary had a total of 147 citations to her work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of her work. The petitioner in this case was a university. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “Her outstanding research has indicated and strengthened the use of ceramide as a therapeutic target for lung cancer treatment and reveals new sides of lipid-protein interaction in human diseases. It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for her outstanding achievements.  With the proof and documentation that we provided, her case was approved in 3 months and 22 days.